References :
- Boo M, van Walraven SM, Chapman J, Lindberg B, Schmidt AH, Shaw BE, et al. Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. Blood 2011; 117(1): 21-5.
- Okas M. Novel Immunothrapeutical strategies in allogeneic hematopoietic stem cell transplantation [dissertation]. Sweden : Karolinska Institute; 2010. p. 9.
- Thomas ED. A history of hematopoietic cell transplantation. Br J Haematol 1999; 105(2): 330-9.
- Gluckman E. A brief History of Haematopoietic Stem Cell Transplantation. Eurocords documents 2011; Chapter 1. p. 1-4. Available from: http://www.eurocord-ed.org/download_docs_embed/_PARTNERS_FOLDER_/chapter1gluckmaneshebmt2012.pdf.
- Grewal SS1, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101(11): 4233-44.
- Wu T. Alternative donor hematopoietic stem cell transplantation: current concepts. ISBT Science Series 2011; 6: 328-31.
- Perez LE. Outcomes from unrelated donor hematopoietic stem cell transplantation. Cancer Control 2011; 18(4): 216-21.
- Chell JW. HSC donor Registries. In: Thomas.ED, Blum KG, Forman G, Appelbaum FR. Thomas' Hematopoietic Stem Cell Transplantation. 3rd ed. USA: Blackwell Publishing; 2004. p. 624-35.
- Hurley CK, Raffoux C; World Marrow Donor Association. World Marrow Donor Association: international standards for unrelated hematopoietic stem cell donor registries. Bone Marrow Transplant 2004; 34(2): 103-10.
- Baldomero H, Passweg J. Hematopoetic Stem Cell Transplantation In Europe: Data and trends in 2011. EBMT Annual Report 2012; 12: 10.
- Apperley J, Keating A. Stem cell transplant organizations. In: Apperley J, Carreras E, Gluckman E, Masszi T. EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation. Switzerland: EMBT; 2012. p. 19-33.
- Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A, et al. Haematopoietic stem cell donor registries: World Marrow Donor Association
recommendations for evaluation of donor health.
Bone Marrow Transplant 2008; 42(1): 9-14.
- WMDA International Standards for Unrelated Hematopoietic Stem Cell Donor Registries; 2012. Available from: http://www. worldmarrow. org/fileadmin/ Committees/STDC/20120101-STDC-WMDA_Standards.pdf.
- Popplewell LL, Forman SJ. Is there an upper age limit for bone marrow transplantation? Bone Marrow Transplant 2002; 29(4): 277-84.
- Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, et al. Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood 2013; 121(13): 2567-73.
- Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98(7): 2043-51.
- World Marrow Donor Association. WMDA International Standards for Unrelated Hematopoietic Stem Cell Donor Registries; 2012. Available from: http://www.worldmarrow.org/fileadmin/Committees/STDC/20120101-STDC-WMDA_Standards.pdf.
- Schmidt AH, Amer B, Halet M, Hildebrand S, Sacchi N. Qualifications and training of adult stem cell donor recruiters: recommendations by the World Marrow Donor Association. Bone Marrow Transplant 2013; 48(1): 148-50.
- World Marrow Donor Association. WMDA International Standards for Unrelated Hematopoietic Stem Cell Donor Registries; 2012. p. 15.
- Petersdorf EW, Anasetti C, Martin PJ, Hansen JA. Tissue typing in support of unrelated hematopoietic cell transplantation. Tissue Antigens 2003; 61(1): 1-11.
- Valcárcel D, Sierra J, Wang T, Kan F, Gupta V, Hale GA, et al. One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biol Blood Marrow Transplant 2011; 17(5): 640-8.
- Bergstrom TC, Garratt R, Sheehan-Connor D. One Chance in a Million: Altruism and the Bone Marrow Registry. American Economic Review 2007; 99(4): 1-41.
- Dickinson AM. Non-HLA immunogenetics and role in transplant outcome. In: EBMT-ESH Handbook on Haemopoietic Stem Cell Transplantation; 2012. p. 79-91.
- Shaiegan M. Stem cell therapy and research status in Iran: at A glance. Iranian Journal of Blood and Cancer 2010; 2(3): 99-100.
- Shaiegan M, Yari F, Abolghasemi H, Bagheri N, Paridar M , Heidari A et al. Allele Frequencies of HLA-A, B and DRB1 among People of Fars Ethnicity Living in Tehran. Iranian Journal of Blood and Cancer 2011; 4: 55-9.
- Shaiegan M, Abolghasemi H, Yari F, Paridar M, Maghsudlu M, Amini Kafiabad S, et al. Comparison of Human Leukocyte Antigen Frequency in Iranian unrelated Stem cell donors during 2011-2012. Sci J Iran Blood Transfus Organ 2013; 10(3): 267- 81.
[Article in Farsi]
- Abroun S. Cord Blood Banks: From the inception. Sci J Blood Transfus Organ 2014; ahead of print. [Article in Farsi]
- Hamidieh AA. Stem cell donation: Barrier to incurable diseases. Iran Newspaper (2012 July 1); p. 14. [Farsi]
- van Rood. J. Feature article: Global medicine Past, Present and Future Challenges. EBMT Annual Report 2012; 12: 8-9.
Sci J Iran Blood Transfus Organ 2014; 11(2): 164-176
|
Unrelated stem cell donor registries in the world
and Iran
Shaiegan M.1, Zolfaghari Anaraki S.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract
Background and Objectives
It is more than 5 decades that hematopoietic stem cell transplantation (HSCT) has been used for treatment of hematologic malignancies, metabolic disordes, and immunodeficiencies. (HLA)-matched HSCT is commonly the preferred type of transplantation, with HLA-matched sibling donors usually the first choice. If there is no related HLA-matched donor, unrelated matched donors are considered.
Materials and Methods
The present article shows the importance of unrelated stem cell donor registries, related regulations and policies, HSCT history, the importance of donor-recipient HLA matching to GVHD inhibition, several donor selection measures, establishment requirements of such registries in the world and Iran, using 29 different references in order to introduce these centers to interested researchers.
Results
These Registries rely on positive feelings of unrelated donors to altruistic donation to save patients. Registries from different countries joined and established world and international donor associations and groups to facilitate finding a suitable donor and improve the HSCT outcomes from unrelated donors.
Conclusions
Huge progress has been made since the first HSCT to save many patients indebted to the efforts of a few pioneers, group collaborations, and international exchanges of stem cell practiced by international organizations which follow definite standards.
Key words: Stem Cells, Unrelated Donors, Iran, Registry
Received: 23 Sep 2013
Accepted: 5 Mar 2014
Correspondence: Shaiegan M., PhD of Immunology. Associate Professor of Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 88601564; Fax: (+9821) 88601599
E-mail:
M.Shaiegan@ibto.ir